期刊文献+

一种模拟心脏血流形态的药物洗脱支架的药物释放装置

A Drug Delivery Device for Drug-eluting Stents Simulating the Cardiovascular Blood Flow Pattern
下载PDF
导出
摘要 该文介绍了一种新型模拟心脏血流形态的药物释放装置,利用该装置来模拟人体生理环境下药物洗脱支架中药物的释放。实验结果表明,该装置测定释放度的结果满足试验规律,具有一定的体内外相关性,从而说明本装置具备作为体外释放度测定方法的价值。 A novel drug delivery device simulating the cardiovascular bloodfl ow pattern was introduced. The device was used to simulate the in vivo drug release in the drug-eluting stents. The results regarding the drug release rate were subject to the pattern from in vivo measurement. Therefore, the device was validated as a measurement method for in vivo drug release rate.
出处 《中国医疗器械杂志》 2016年第5期322-325,共4页 Chinese Journal of Medical Instrumentation
基金 上海市科委课题(13441902600)
关键词 释放装置 药物洗脱支架 雷帕霉素 simulating dissolution device drug-eluting stent rapamycin
  • 相关文献

参考文献7

  • 1钟杨,武衡,成志,余雁,屈小勇,张群锋.雷帕霉素抑制血管平滑肌细胞增殖的研究进展[J].临床和实验医学杂志,2009,8(4):130-131. 被引量:3
  • 2Schiele TM. Current understanding of coronary in-stentrestenosis[J]. Z Kardiol, 2005, 94 (11): 772-790.
  • 3陈玉成,熊素彬,幸浩洋,曾智,齐民.雷帕霉素缓释涂层支架在模拟心脏泵血状态下的体外释药研究[J].中国药学杂志,2008,43(9):688-688. 被引量:6
  • 4中华人民共和国药典委员会编.9013缓释、控释和迟释制剂指导原则[z].中华人民共和国药典2015年版四部,2015: 368-370.
  • 5Food and Drug Administration, US Department of Health andHuman Services. Guidnce for industry-coronary drug-elutingstents-nonclinical and clinical studies DRAFT GUIDANCE[S].2008.
  • 6奚廷斐.药物洗脱支架评价指南[R/OL].http://upload.haoyisheng.com/conference/20090220/ywxtzjpjzn.ppt.
  • 7Ma XD, Oyamada S, Gao F, et al. Paclitaxel/sirolimuscombinationcoated drug-eluting stent: in vitro and in vivo drugrelease studies[J]. J Pharm Biomed Anal, 2011, 54 (4): 807-811.

二级参考文献11

  • 1尹民,袁媛,刘昌胜.316L不锈钢表面聚乙烯-乙烯醇药物涂层的制备及性能[J].华东理工大学学报(自然科学版),2005,31(3):386-389. 被引量:3
  • 2李锐洁,李静,陈玉成,曾智.药物洗脱支架治疗冠状动脉疾病的Meta分析[J].中国循证医学杂志,2005,5(7):519-535. 被引量:10
  • 3SCHIELE T M. Current understanding of coronary in-stent restenosis[J]. Z Kardiol,2005,94 ( 11 ) :772-790.
  • 4HOFFMANN R, MINTZ G S, DUSSAILLANT G R,et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study [ J ]. Circulation, 1996,94 (6) : 1247-1254.
  • 5MORICE M C, SERRUYS P W, SOUSA J E,et al. Randomized study with the sirolimus-coated bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[ J]. N Engl J Med,2002,346 : 1773-1780.
  • 6GRUBE E, SILBER S, HAUPTMANN K E,et al. TAXUS I: sixand twelve-month results from a randomized, double-blind trial on a slow-release paclitaxeleluting stent for de novo coronary lesions[ J]. Circulation,2003,107 : 38-42.
  • 7LINCOFF A M, TOPOL E J, ELLIS S G. Local drug delivery for the prevention of restenosis : fact, fancy, and future [J].Circulation, 1994,90 : 2070 -2084.
  • 8FRANK A, SUBBU S V ,et al. In vitro study of release mechanisms of paclitaxel and rapamycin frum drug-incorporated biodegradable stent matrices [ J ]. J Controlled Release ,2004 ,98 :67-74.
  • 9CRRISTEN T, VERIN V, BOCHATON-PIALLAT M, et al. Mechanisms of neointima formation and remodeling in the porcine coronary artery [ J ]. Circulation,2001,103 (6) :882-888.
  • 10徐仓宝,张亚萍,李玉华.内皮和平滑肌相互作用与动脉粥样硬化发生机制的研究进展[J].西安医科大学学报,1999,20(1):129-132. 被引量:6

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部